Researchers Developed AI to Map Genetic Mutations
The new GPN-Star model identifies disease-linked variants across the human genome by analyzing evolutionary history.
Updated on Sept. 20, 2026 in Life Sciences

Live Poll
Do you trust AI models to accurately prioritize which genetic research experiments to conduct?
Researchers at the University of California, Berkeley, have created GPN-Star, an AI model designed to predict which genetic variants are likely to cause disease. By comparing human DNA against the evolutionary history of hundreds of other species, the tool identifies critical genetic positions.
Why it matters
Understanding which mutations are functionally significant is essential for identifying the roots of human disease, as evolution naturally preserves important DNA sequences. This new model offers a high-efficiency way to interpret the vast landscape of the human genome.
The GPN-Star model trained in several days using only eight processors to analyze 600 million years of vertebrate evolutionary history. It provides predictions for every possible single-letter change across the 3 billion letters of the human genome.
The players
University of California, Berkeley
This public research university served as the primary base for the development of the GPN-Star model.
Innovative Genomics Institute
This research organization is affiliated with the team that developed the new genetic AI.
The details
The model assesses how strongly evolution protected a specific genetic position over millions of years, as mutations in critical DNA tend to become rarer. While only 1% to 2% of human DNA codes for proteins, this tool helps researchers pinpoint disease-driving variants across the entire genomic sequence.
Timeline
September 20, 2026: The research findings were published in the journal Nature.
The Big Picture
The study follows the pattern set by the Human Genome Project by providing the scientific community with comprehensive maps of human genetic variation. This development shifts the discipline by enabling automated, genome-wide functional predictions rather than relying on manual analysis of specific genes.
This research could eventually accelerate the development of personalized medical treatments by pinpointing the specific genetic causes of rare conditions. By making these predictions public, the researchers enable future studies to focus on high-priority variants more efficiently.
The takeaway
GPN-Star demonstrates that comparing human DNA with the evolutionary records of other vertebrates is a powerful method for identifying disease risks. Researchers and clinicians can use these public variant predictions to better understand the genetic underpinnings of 106 different human traits.
Further reading
For more on emerging research in this field, visit Life Sciences.
Source note: This article includes information reported by Earth.
Live Poll
Do you trust AI models to accurately prioritize which genetic research experiments to conduct?










